_JIRAROJ_PRADITCHAROENKUL_Alamy.jpg?#)
_Tanapong_Sungkaew_Alamy.jpg?#)
Life sciences: Primed for an increase
M&A activity in the life science sector fell in 2024, but several factors, including pent-up demand and the state of companies’ pipelines, point to a strong rebound in dealmaking in 2025.
M&A activity in the life science sector fell in 2024, but several factors, including pent-up demand and the state of companies’ pipelines, point to a strong rebound in dealmaking in 2025.
